GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients
if (g_displayableSlots.mobileTopLeaderboard) {
pushDisplayAd(function() { googletag.display('div-gpt-mobile-top-leaderboard'); });
}
Karolinska InstitutetJun 20 2024
People with type 2 diabetes who are…
Read More...
Read More...